0001193125-15-294693.txt : 20150818 0001193125-15-294693.hdr.sgml : 20150818 20150818170107 ACCESSION NUMBER: 0001193125-15-294693 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150814 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20150818 DATE AS OF CHANGE: 20150818 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XENOPORT INC CENTRAL INDEX KEY: 0001130591 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943330837 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-51329 FILM NUMBER: 151061991 BUSINESS ADDRESS: STREET 1: 3410 CENTRAL EXPRESSWAY CITY: SANTA CLARA STATE: CA ZIP: 95051 BUSINESS PHONE: 4086167200 MAIL ADDRESS: STREET 1: 3410 CENTRAL EXPRESSWAY CITY: SANTA CLARA STATE: CA ZIP: 95051 8-K 1 d13930d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): August 14, 2015

 

 

XENOPORT, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   000-51329   94-3330837

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

3410 Central Expressway

Santa Clara, California 95051

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (408) 616-7200

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Section 5—Corporate Governance and Management

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 14, 2015, the Board of Directors (the “Board”) of XenoPort, Inc. (the “Company”), upon the recommendation of the Compensation Committee of the Board, approved a base salary increase for and the grant of certain equity awards to Vincent J. Angotti, the Company’s Chief Operating Officer, to improve the retention value of Mr. Angotti’s compensatory arrangements with the Company. In particular, the Board approved an increase in Mr. Angotti’s annual base salary to $500,000, and approved the grant of a stock option to purchase 118,540 shares of the Company’s common stock (the “Option”) and the grant of a restricted stock unit award covering 151,516 shares of the Company’s common stock (the “RSUs”). The Option and the RSUs were granted under the Company’s 2014 Equity Incentive Plan previously approved by the Company’s stockholders. The Option carries a per share exercise price of $6.47, the closing sales price of the Company’s common stock on the August 14, 2015 grant date, and will vest in a series of forty-eight successive equal monthly installments over the four-year period measured from the August 14, 2015 grant date, subject to continuous service. The RSUs will vest in four equal annual installments on each anniversary of the August 14, 2015 grant date, subject to continuous service. Each of the Option and the RSUs are also subject to vesting acceleration under certain circumstances as set forth in the previously-disclosed severance rights agreement between the Company and Mr. Angotti.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    XENOPORT, INC.
    (Registrant)
Dated: August 18, 2015     By:  

/s/ William G. Harris

      William G. Harris
      Senior Vice President of Finance and
      Chief Financial Officer